RE:RE:New poster on liver inflammation at EndoProbably right. Those endocrine types just can't keep a secret.... Maybe get it to PR outlets Monday.
Dr. Stanley and Fourman at it again with genetic analysis. This time for immune system effects as measured in the blood plasma from the Phase 2 participants. I think they've learned as much, if not more, about the MOA of their drug on the liver via the 90 person NAFLD Phase 2 trial than others at this stage. They are real assets to Grinspoons lab and this project. Looks like it extends their previous genetic work that hinted at impacting genes involved in liver cancer. Adds another way the drug interacts with the liver and, this time, the immune system for the liver, to bring it back to health like they saw in the trial. Solid!
jfm1330 wrote: Maybe it's the reason for the little rise of the last few days.
jfm1330 wrote: Strange to publish that on a friday night.
https://www.abstractsonline.com/pp8/#!/9188/presentation/2240
https://www.theratech.com/theratechnologies-announces-new-data-demonstrating-tesamorelins-positive-effect-on-immune-response-linked-to-liver-inflammation/